Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 112

1.

Collapse of the Plasmacytoid Dendritic Cells compartment in advanced cutaneous melanomas by components of the tumor cell secretome.

Vescovi R, Monti M, Moratto D, Paolini L, Consoli F, Benerini Gatta L, Melocchi L, Calza S, Chiudinelli M, Rossi G, Bugatti M, Maio M, Fonsatti E, Farisoglio C, Simbolo M, Almici C, Verardi R, Scarpa A, Bergese P, Manganoni A, Facchetti F, Vermi W.

Cancer Immunol Res. 2018 Nov 6. pii: canimm.0141.2018. doi: 10.1158/2326-6066.CIR-18-0141. [Epub ahead of print]

PMID:
30401679
2.

Pityriasis Lichenoides, Atypical Pityriasis Lichenoides, and Related Conditions: A Study of 66 Cases.

Borra T, Custrin A, Saggini A, Fink-Puches R, Cota C, Vermi W, Facchetti F, Cerroni L.

Am J Surg Pathol. 2018 Aug;42(8):1101-1112. doi: 10.1097/PAS.0000000000001093.

PMID:
29851705
3.

NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines.

Huergo-Zapico L, Parodi M, Cantoni C, Lavarello C, Fernández-Martínez JL, Petretto A, DeAndrés-Galiana EJ, Balsamo M, López-Soto A, Pietra G, Bugatti M, Munari E, Marconi M, Mingari MC, Vermi W, Moretta L, González S, Vitale M.

Cancer Res. 2018 Jul 15;78(14):3913-3925. doi: 10.1158/0008-5472.CAN-17-1891. Epub 2018 May 11.

PMID:
29752261
4.

slan+ Monocytes and Macrophages Mediate CD20-Dependent B-cell Lymphoma Elimination via ADCC and ADCP.

Vermi W, Micheletti A, Finotti G, Tecchio C, Calzetti F, Costa S, Bugatti M, Calza S, Agostinelli C, Pileri S, Balzarini P, Tucci A, Rossi G, Furlani L, Todeschini G, Zamò A, Facchetti F, Lorenzi L, Lonardi S, Cassatella MA.

Cancer Res. 2018 Jul 1;78(13):3544-3559. doi: 10.1158/0008-5472.CAN-17-2344. Epub 2018 May 10.

PMID:
29748373
5.

A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro: Failure to Reproducibly Detect It.

Tamassia N, Arruda-Silva F, Calzetti F, Lonardi S, Gasperini S, Gardiman E, Bianchetto-Aguilera F, Gatta LB, Girolomoni G, Mantovani A, Vermi W, Cassatella MA.

Front Immunol. 2018 Apr 17;9:795. doi: 10.3389/fimmu.2018.00795. eCollection 2018.

6.

Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition.

Giurisato E, Xu Q, Lonardi S, Telfer B, Russo I, Pearson A, Finegan KG, Wang W, Wang J, Gray NS, Vermi W, Xia Z, Tournier C.

Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2801-E2810. doi: 10.1073/pnas.1707929115. Epub 2018 Mar 5.

7.

Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor.

Barrow AD, Edeling MA, Trifonov V, Luo J, Goyal P, Bohl B, Bando JK, Kim AH, Walker J, Andahazy M, Bugatti M, Melocchi L, Vermi W, Fremont DH, Cox S, Cella M, Schmedt C, Colonna M.

Cell. 2018 Jan 25;172(3):534-548.e19. doi: 10.1016/j.cell.2017.11.037. Epub 2017 Dec 21.

PMID:
29275861
8.

Two Distinct Myeloid Subsets at the Term Human Fetal-Maternal Interface.

Costa ML, Robinette ML, Bugatti M, Longtine MS, Colvin BN, Lantelme E, Vermi W, Colonna M, Nelson DM, Cella M.

Front Immunol. 2017 Oct 25;8:1357. doi: 10.3389/fimmu.2017.01357. eCollection 2017.

9.

Helicobacter pylori Affects the Antigen Presentation Activity of Macrophages Modulating the Expression of the Immune Receptor CD300E through miR-4270.

Pagliari M, Munari F, Toffoletto M, Lonardi S, Chemello F, Codolo G, Millino C, Della Bella C, Pacchioni B, Vermi W, Fassan M, de Bernard M, Cagnin S.

Front Immunol. 2017 Oct 12;8:1288. doi: 10.3389/fimmu.2017.01288. eCollection 2017.

10.

Potential contribution of tumor-associated slan+ cells as anti-CSF-1R targets in human carcinoma.

Lonardi S, Licini S, Micheletti A, Finotti G, Vermi W, Cassatella MA.

J Leukoc Biol. 2018 Mar;103(3):559-564. doi: 10.1189/jlb.1MA0717-300R. Epub 2017 Dec 28.

PMID:
28951423
11.

Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis.

Roca E, Gurizzan C, Amoroso V, Vermi W, Ferrari V, Berruti A.

Cancer Treat Rev. 2017 Sep;59:117-122. doi: 10.1016/j.ctrv.2017.07.007. Epub 2017 Jul 31. Review.

PMID:
28806542
12.

Role of MyD88 signaling in the imiquimod-induced mouse model of psoriasis: focus on innate myeloid cells.

Costa S, Marini O, Bevilacqua D, DeFranco AL, Hou B, Lonardi S, Vermi W, Rodegher P, Panato A, Tagliaro F, Lowell CA, Cassatella MA, Girolomoni G, Scapini P.

J Leukoc Biol. 2017 Sep;102(3):791-803. doi: 10.1189/jlb.3MA0217-054RR. Epub 2017 Jun 22.

PMID:
28642279
13.

An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition.

Young HL, Rowling EJ, Bugatti M, Giurisato E, Luheshi N, Arozarena I, Acosta JC, Kamarashev J, Frederick DT, Cooper ZA, Reuben A, Gil J, Flaherty KT, Wargo JA, Vermi W, Smith MP, Wellbrock C, Hurlstone A.

J Exp Med. 2017 Jun 5;214(6):1691-1710. doi: 10.1084/jem.20160855. Epub 2017 Apr 27.

14.

IL-21 May Promote Granzyme B-Dependent NK/Plasmacytoid Dendritic Cell Functional Interaction in Cutaneous Lupus Erythematosus.

Salvi V, Vermi W, Cavani A, Lonardi S, Carbone T, Facchetti F, Bosisio D, Sozzani S.

J Invest Dermatol. 2017 Jul;137(7):1493-1500. doi: 10.1016/j.jid.2017.03.016. Epub 2017 Mar 23.

15.

Mature CD10+ and immature CD10- neutrophils present in G-CSF-treated donors display opposite effects on T cells.

Marini O, Costa S, Bevilacqua D, Calzetti F, Tamassia N, Spina C, De Sabata D, Tinazzi E, Lunardi C, Scupoli MT, Cavallini C, Zoratti E, Tinazzi I, Marchetta A, Vassanelli A, Cantini M, Gandini G, Ruzzenente A, Guglielmi A, Missale F, Vermi W, Tecchio C, Cassatella MA, Scapini P.

Blood. 2017 Mar 9;129(10):1343-1356. doi: 10.1182/blood-2016-04-713206. Epub 2017 Jan 4. Erratum in: Blood. 2017 Jun 15;129(24):3271.

16.

Correction: slanDCs/M-DC8+ cells constitute a distinct subset of dendritic cells in human tonsils.

Micheletti A, Finotti G, Calzetti F, Lonardi S, Zoratti E, Bugatti M, Stefini S, Vermi W, Cassatella MA.

Oncotarget. 2016 Oct 4;7(40):66323. doi: 10.18632/oncotarget.12418. No abstract available.

17.

Dendritic cell-derived VEGF-A plays a role in inflammatory angiogenesis of human secondary lymphoid organs and is driven by the coordinated activation of multiple transcription factors.

Salvi V, Vermi W, Gianello V, Lonardi S, Gagliostro V, Naldini A, Sozzani S, Bosisio D.

Oncotarget. 2016 Jun 28;7(26):39256-39269. doi: 10.18632/oncotarget.9684.

18.

Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas.

Griffith OL, Chan SR, Griffith M, Krysiak K, Skidmore ZL, Hundal J, Allen JA, Arthur CD, Runci D, Bugatti M, Miceli AP, Schmidt H, Trani L, Kanchi KL, Miller CA, Larson DE, Fulton RS, Vermi W, Wilson RK, Schreiber RD, Mardis ER.

Cell Rep. 2016 Sep 27;17(1):249-260. doi: 10.1016/j.celrep.2016.08.076.

19.

TLR Signalling Pathways Diverge in Their Ability to Induce PGE2.

Salvi V, Vaira X, Gianello V, Vermi W, Bugatti M, Sozzani S, Bosisio D.

Mediators Inflamm. 2016;2016:5678046. doi: 10.1155/2016/5678046. Epub 2016 Aug 18.

20.

p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity.

Adriaens C, Standaert L, Barra J, Latil M, Verfaillie A, Kalev P, Boeckx B, Wijnhoven PW, Radaelli E, Vermi W, Leucci E, Lapouge G, Beck B, van den Oord J, Nakagawa S, Hirose T, Sablina AA, Lambrechts D, Aerts S, Blanpain C, Marine JC.

Nat Med. 2016 Aug;22(8):861-8. doi: 10.1038/nm.4135. Epub 2016 Jul 4.

PMID:
27376578

Supplemental Content

Loading ...
Support Center